Literature DB >> 20091080

Fat replacement of the malignant pancreatic tissue after neoadjuvant therapy.

Ozer Makay1, Mircelal Kazimi, Unal Aydin, Deniz Nart, Funda Yilmaz, Murat Zeytunlu, Erdem Goker, Ahmet Coker.   

Abstract

Pancreatic lipomatosis is characterized as massive lipid infiltration of the pancreatic tissue. Although its etiology is ill defined; obesity, diabetes mellitus, chronic pancreatitis, hereditary pancreatitis, and conditions that cause pancreatic ductal obstruction, for example tumors and stones, are related to its pathogenesis. Recently, with the increased use of computerized tomography and magnetic resonance imaging, it has become possible to observe the fat replacement of the pancreas. Herein, we report a 60-year-old man complaining of abdominal pain and weight loss. Preoperative work-up revealed a locally advanced (Stage III) pancreatic adenocarcinoma. Multimodal treatment was carried out and a 100% complete response was detected after neoadjuvant therapy. The patient underwent a standard pancreaticoduodenectomy, without complications. The tissue pathology revealed lipomatosis of the pancreas. He was disease-free and symptom-free at 1 year follow-up. To our knowledge, this is the first report in the literature of pancreatic head carcinoma with total fat replacement of the pancreas after neoadjuvant chemoradiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20091080     DOI: 10.1007/s10147-009-0001-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  14 in total

1.  Lipomatous pseudohypertrophy of the pancreas.

Authors:  O D BERESFORD; T K OWEN
Journal:  J Clin Pathol       Date:  1957-02       Impact factor: 3.411

2.  Focal fatty replacement of the pancreas: usefulness of chemical shift MRI.

Authors:  Hye Jin Kim; Jae Ho Byun; Seong Ho Park; Yong Moon Shin; Pyo Nyun Kim; Hyun Kwon Ha; Moon-Gyu Lee
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

3.  Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase.

Authors:  Helge Raeder; Ingfrid S Haldorsen; Lars Ersland; Renate Grüner; Torfinn Taxt; Oddmund Søvik; Anders Molven; Pål R Njølstad
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

Review 4.  Total fat replacement of the pancreas: case report and review of the literature.

Authors:  F Rosseel; E Brugman; J Fiey; T Goddeeris; E Bucuk; J Friberg
Journal:  J Belge Radiol       Date:  1996-11

5.  Sonographic findings in pancreatic lipomatosis.

Authors:  C B So; P L Cooperberg; R G Gibney; A Bogoch
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

6.  Lipomatous pseudohypertrophy of the pancreas associated with chronic pulmonary suppuration in an adult.

Authors:  D I Siegler
Journal:  Postgrad Med J       Date:  1974-01       Impact factor: 2.401

7.  Computed tomography and ultrasonography findings for an adult with Shwachman syndrome and pancreatic lipomatosis.

Authors:  S A MacMaster; T M Cummings
Journal:  Can Assoc Radiol J       Date:  1993-08       Impact factor: 2.248

8.  Huge lipomatous pseudohypertrophy of the pancreas.

Authors:  M Nakamura; N Katada; A Sakakibara; N Okumura; E Kato; M Takeichi; T Kondo; H Mano
Journal:  Am J Gastroenterol       Date:  1979-08       Impact factor: 10.864

9.  Adipose atrophy of the exocrine pancreas.

Authors:  M N Walters
Journal:  J Pathol Bacteriol       Date:  1966-10

Review 10.  Diffuse Mallory bodies in the liver, diffuse Lewy bodies in the brain and diffuse fat replacement (lipomatous pseudohypertrophy) of the pancreas in a patient with juvenile Parkinson's disease.

Authors:  N Yoshimura; S Hayashi; Y Fukushima
Journal:  Acta Pathol Jpn       Date:  1992-11
View more
  9 in total

1.  Pancreatic duct ligation after almost complete β-cell loss: exocrine regeneration but no evidence of β-cell regeneration.

Authors:  Claudia Cavelti-Weder; Maria Shtessel; Joshua E Reuss; Agnes Jermendy; Takatsugu Yamada; Francisco Caballero; Susan Bonner-Weir; Gordon C Weir
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

Review 2.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 3.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

Review 4.  Imaging findings of lipomatosis: a comprehensive review.

Authors:  Seray Akcalar; Baris Turkbey; Tuncay Hazirolan; Musturay Karcaaltincaba; Iclal Ocak; Ustun Aydingoz; Erhan Akpinar
Journal:  Jpn J Radiol       Date:  2012-10-10       Impact factor: 2.374

5.  Total pancreatic lipomatosis with malabsorption syndrome.

Authors:  Rama Anand; Mahender K Narula; Vikas Chaudhary; Rohini Agrawal
Journal:  Indian J Endocrinol Metab       Date:  2011-01

Review 6.  Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.

Authors:  Roberto Catanzaro; Biagio Cuffari; Angelo Italia; Francesco Marotta
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

7.  Pancreatic alpha-cell mass across adult human lifespan.

Authors:  Abu Saleh Md Moin; Megan Cory; Tatyana Gurlo; Yoshifumi Saisho; Robert A Rizza; Peter C Butler; Alexandra E Butler
Journal:  Eur J Endocrinol       Date:  2020-02       Impact factor: 6.664

8.  Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma.

Authors:  Vishal Desai; Kevin Patel; Ravi Sheth; Usman Barlass; Yuet-Ming Chan; Joy Sclamberg; Faraz Bishehsari
Journal:  Visc Med       Date:  2020-05-05

9.  Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma.

Authors:  Mika Hori; Mami Takahashi; Nobuyoshi Hiraoka; Taiki Yamaji; Michihiro Mutoh; Rikako Ishigamori; Koh Furuta; Takuji Okusaka; Kazuaki Shimada; Tomoo Kosuge; Yae Kanai; Hitoshi Nakagama
Journal:  Clin Transl Gastroenterol       Date:  2014-03-13       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.